REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1

Q3 2023 13F Holders as of 9/30/2023

Type / Class
Debt / NOTE 1.750% 2/1
Number of holders
29
Total Principal
246M
Shares change
+14.7M
Total reported value, excl. options
$199M
Value change
+$8.92M
Put/Call ratio
0
Number of buys
14
Number of sells
-16
Price
$0.80
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.